Paraganglioma del órgano de Zuckerkandl
Palabras clave:
cuerpos paraaórticos, órgano de Zuckerkandl, paraganglioma, feocromocitoma, hipertensiónResumen
Los paragangliomas del órgano de Zuckerkandl son un problema clínico infrecuente. Aunque los pacientes pre- sentan síntomas característicos, como hipertensión arterial de difícil manejo, cefalea y palpitaciones, su diagnóstico se debe considerar de exclusión.
En este artículo se hace una revisión de la literatura y se presenta con caso clínico.
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. McNicol AM. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas. Endocr Pathol. 2006;17:329-36.
https://doi.org/10.1007/s12022-006-0004-2
2. Kantorovich V, Pacak K. Pheochromocytoma and paraganglioma. Prog Brain Res. 2010;182:343-73.
https://doi.org/10.1016/S0079-6123(10)82015-1
3. Glenn F, Gray GF. Functional tumors of the organ of Zuckerkandl. Ann Surg. 1976;183:578-86.
https://doi.org/10.1097/00000658-197605000-00015
4. Roman S. Pheochromocytoma and functional paraganglioma. Curr Opin Oncol. 2004;16:8-12.
https://doi.org/10.1097/00001622-200401000-00003
5. Subramanian A, Maker VK. Organs of Zuckerkandl: Their surgical significance and a review of a century of literature. Am J Surg. 2006;192:224-34.
https://doi.org/10.1016/j.amjsurg.2006.02.018
6. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827-36.
https://doi.org/10.1210/jc.2005-1862
7. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Pheochromocytoma: An update on genetics and management. Endocr Relat Cancer. 2007;14:935-56.
https://doi.org/10.1677/ERC-07-0142
8. Tischler AS, Kimura N, McNicol AM. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann N Y Acad Sci. 2006;1073:557-70.
https://doi.org/10.1196/annals.1353.059
9. McNichol AM. Differential diagnosis of pheochromocytomas and paragangliomas. Endocr Pathol. 2001;12:407-15.
https://doi.org/10.1385/EP:12:4:407
10. McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma. Histopathology. 2010 Aug 16. [Epub ahead of print].
https://doi.org/10.1111/j.1365-2559.2010.03613.x
11. Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med. 2008;132:1272-84.
12. Álvarez TR, Álvarez T, Portela O, Olvera BC, Burgos ZA. Feocromocitoma. Presentación de un caso y revisión de la lite- ratura. Rev Mex Cir Endoscop. 2007;8:148-56.
13. Álvarez R. Feocromocitoma. Presentación de un caso y revisión de la literatura. Asociación Mexicana de Cirugía Endoscópica, AC. 2007;8:148-56.
14. Arroyo-MartínezL,Álvarez-PertuzH,Acuña-CalvoJ,Montoya- Calles J. Paraganglioma funcional extra-adrenal. Acta Méd Costarric. 2006;48:39-42.
15. Hayes WS, Davidson AJ, Grimley PM, Hartman DS. Extraadrenal retroperitoneal paraganglioma: Clinical, pathologic, and CT findings. AJR Am J Roentgenol. 1990;155:1247-50.
https://doi.org/10.2214/ajr.155.6.2173385
16.Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665-75.
https://doi.org/10.1016/S0140-6736(05)67139-5
17. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, et al. Pheochromocytoma: Current approaches and future directions. Oncologist. 2008;13:779-93.
https://doi.org/10.1634/theoncologist.2008-0043
18. Liao CH, Chueh SC, Lai MK, Hsiao PJ, Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab. 2006;91:3080-3.
https://doi.org/10.1210/jc.2005-2420
19. Portela-Gomes GM, Stridsberg M, Grimelius L, Falkmer UG, Falkmer S. Expression of chromogranins A, B, and C secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies. APMIS. 2004;112:663-73.
https://doi.org/10.1111/j.1600-0463.2004.t01-1-apm1121005.x
20. Elder EE, Xu D, Hoog A, Enberg U, Hou M, Pisa P, et al. KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol. 2003;16:246-55.
https://doi.org/10.1097/01.MP.0000056982.07160.E3
21. Sotolongo Y, Vigoa L, Pérez J. Feocromocitoma y anestesia: revisión del tema a propósito de un caso. Rev Cubana Cir [online]. 2002;414). Disponible en http://bvs.sld.cu/revistas/cir/ vol41_4_02/cir11402.htm
22.Mittendorf EA, Evans DB, Lee JE, Perrier ND. Pheochromocytoma: Advances in genetics, diagnosis, localization, and treatment. Hematol Oncol Clin North Am. 2007;21:509-25.
https://doi.org/10.1016/j.hoc.2007.04.012
23. Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am. 2007;21:409-32.
https://doi.org/10.1016/j.hoc.2007.04.006
24. Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G, et al. Laparoscopic surgery for pheochromocytoma: Adrenalectomy, partial resection, excision of paragangliomas. J Urol. 1998;160:330-4.
https://doi.org/10.1016/S0022-5347(01)62886-6
25. Cascon A, Pita G, Burnichon N, Landa I, López-Jiménez E, Montero-Conde C, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab. 2009;94:1701-5.
https://doi.org/10.1210/jc.2008-2756
26. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92:779-86.
https://doi.org/10.1210/jc.2006-2315
27. Malone MJ, Libertino JA, Tsapatsaris NP, Woods BO. Preoperative and surgical management of pheochromocytoma. Urol Clin North Am. 1989;16:567-82.
28. Ilias I, Pacak K. A clinical overview of pheochromocytomas/ paragangliomas and carcinoid tumors. Nucl Med Biol. 2008;35(Suppl.1):S27-34.
https://doi.org/10.1016/j.nucmedbio.2008.04.007
29. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diag- nosis and treatment of pheochromocytoma in an academic hos- pital from 1997 to 2007. Am J Med. 2009;122:85-95.
https://doi.org/10.1016/j.amjmed.2008.08.021
30. Brain KL, Kay J, Shine B. Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population. Clin Chem. 2006;52:2060-4.
https://doi.org/10.1373/clinchem.2006.070805
31. Goldstein DS, Eisenhofer G, Flynn JA, Wand G, Pacak K. Diag- nosis and localization of pheochromocytoma. Hypertension. 2004;43:907-10.
https://doi.org/10.1161/01.HYP.0000125014.56023.b8
32. Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: A clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol. 2005;16:23-32.
https://doi.org/10.1385/EP:16:1:023
33. Fernández-Cruz L, Taura P, Saenz A, Benarroch G, Sabater L. Laparoscopic approach to pheochromocytoma: Hemodynamic changes and catecholamine secretion. World J Surg. 1996;20:762-8.
https://doi.org/10.1007/s002689900116
34. Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL. Pheochromocytoma and paraganglioma: Comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology. 1987;165:89-93.
https://doi.org/10.1148/radiology.165.1.3628794
35. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: Current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging. 2008;52:419-29.
36. van der Harst E, de Herder W, Bruining H, Jaap Bonjer H, de Krijger R, Lamberts S. [123I]Metaiodobenzylguanidine and [111In]Octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab. 2001;86:685-93.
https://doi.org/10.1210/jc.86.2.685
37. van Der Horst-Schrivers AN, Jager Ol, Boenzen HM, Schouten JP, Kema IP, Links TP. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas-experience and meta-analysis. Anticancer Research, 2006;26:1599-604.
38. Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg. 2005;241:919-26.
https://doi.org/10.1097/01.sla.0000164175.26785.06
39. Tiyadath BN, Sukumar S, Saheed CS, Hattangadi SB. Laparoscopic adrenalectomy - is it any different in phaeochromocytoma and non-phaeochromocytoma? Asian J Surg. 2007;30:244-9.
https://doi.org/10.1016/S1015-9584(08)60033-0
40. Misra MC, Bhattacharjee HK, Hemal AK, Bansal VK. Laparoscopic management of rare retroperitoneal tumors. Surg Laparosc Endosc Percutan Tech. 2010;20:e117-22.
https://doi.org/10.1097/SLE.0b013e3181df2286
41. Hwang J, Shoaf G, Uchio EM, Watson J, Pacak K, Linehan WM, et al. Laparoscopic management of extra-adrenal pheochromocytoma. J Urol. 2004;171:72-6.
https://doi.org/10.1097/01.ju.0000102081.46348.a4
42. Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg. 2002;26:1005-12.
https://doi.org/10.1007/s00268-002-6632-x
43. Edwin B, Kazaryan AM, Mala T, Pfeffer PF, Tonnessen TI, Fosse E. Laparoscopic and open surgery for pheochromocytoma. BMC Surg. 2001;1:2.
https://doi.org/10.1186/1471-2482-1-2
44. Mellon MJ, Sethi A, Sundaram CP. Laparoscopic adrenalectomy: Surgical techniques. Indian J Urol. 2008;24:583-9.
https://doi.org/10.4103/0970-1591.44277
45. Kazaryan AM, Kuznetsov NS, Shulutko AM, Beltsevich DG, Edwin B. Evaluation of endoscopic and traditional open approaches to pheochromocytoma. Surg Endosc. 2004;18:937-41.
https://doi.org/10.1007/s00464-003-9199-1
46. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, et al. Malignant pheochromocytoma: Current status and initiatives for future progress. Endocr Relat Cancer. 2004;11:423-36.
https://doi.org/10.1677/erc.1.00829
47. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H. Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 2007;92:1217-25.
https://doi.org/10.1210/jc.2006-1544
48. Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol. 2002;13:149-56.
https://doi.org/10.1385/EP:13:2:149
49. Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551-66.
https://doi.org/10.1097/00000478-200205000-00002
50.Bedard E, Bergeron S, Poirier P, Dumesnil JG. Pheochromocytoma associated with apical-sparing left ventricular dysfunction due to acute afterload mismatch: A no- vel clinical entity? Can J Cardiol. 2007;23:1157-8.
https://doi.org/10.1016/S0828-282X(07)70888-7
51. Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Moretti A, et al. Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodelling. Eur J Endocrinol. 2008;159:137-43.
https://doi.org/10.1530/EJE-08-0126
52. Kim HS, Chang WI, Kim YC, Yi SY, Kil JS, Hahn JY, et al. Catecholamine cardiomyopathy associated with paraganglioma rescued by percutaneous cardiopulmonary support: Inverted Takotsubo contractile pattern. Circ J. 2007;71:1993-5.
https://doi.org/10.1253/circj.71.1993
53. López M, Águila P, González E. Anestesia en el feocromocitoma: presentación de un paciente. Revista Cubana de Anestesiología y Reanimación. 2004;2:45-8.
54. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069-79.
https://doi.org/10.1210/jc.2007-1720
55. Sesay M, Tauzin-Fin P, Gosse P, Ballanger P, Maurette P. Real- time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery. Anesth Analg. 2008;106:164-70.
https://doi.org/10.1213/01.ane.0000289531.18937.0a
56. Carvalho MR, Dias T, Rodrigues A, Machado AP, Esteves R, do C, I. Alpha blockade with doxazosin in pheochromocytoma - report of three cases. Rev Port Cardiol. 2010;29:299-308.
57. Chiu AW. Laparoscopic retroperitoneal adrenalectomy: Clinical experience with 120 consecutive cases. Asian J Surg. 2003;26:139-44.
https://doi.org/10.1016/S1015-9584(09)60372-9
58. Rabii R, Salomon L, Saint F, Hoznek A, Cicco A, Chopin D, et al. Treatment of pheochromocytomas with retroperitoneal laparoscopy. Prog Urol. 2001;11:16-20.
59. Humphrey R, Gray D, Pautler S, Davies W. Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: A review of 47 cases. Can J Surg. 2008;51:276-80.
60. Kasahara T, Nishiyama T, Takahashi K. Laparoscopic adrenalectomy for pheochromocytoma: Evaluation of experience and strategy at a single institute. BJU Int. 2009;103:218-22.
https://doi.org/10.1111/j.1464-410X.2008.07894.x
61. Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92:512-7.
https://doi.org/10.1093/bja/aeh083
62. O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg. 1996;20:916-21.
https://doi.org/10.1007/s002689900139
63. Shirkare S, Kuwert T, Weckesser M, Czech N, Langen KJ, Muller-Gartner HW. Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy. J Postgrad Med. 1994;40:85-7.
64. Chen L, Li F, Zhuang H, Jing H, Du Y, Zeng Z. 99mTc-HYNIC- TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma. J Nucl Med. 2009;50:397-400.
https://doi.org/10.2967/jnumed.108.058693
65. Suh IW, Lee CW, Kim YH, Hong MK, Lee JW, Kim JJ, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation ECMO) in pheochromocytoma. J Korean Med Sci. 2008;23:350-4.
https://doi.org/10.3346/jkms.2008.23.2.350
66. Neumann HP, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab. 2009;94:2677-83.
https://doi.org/10.1210/jc.2009-0496
67. Benn DE, Robinson BG. Genetic basis of phaeochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2006;20:435-50.
https://doi.org/10.1016/j.beem.2006.07.005
68. Jimenez C, Cote G, Arnold A, Gagel RF. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab. 2006;91:2851-8.
https://doi.org/10.1210/jc.2005-2178
69. Boedeker CC, Neumann HP, Offergeld C, Maier W, Falcioni M, Berlis A, et al. Clinical features of paraganglioma syndromes. Skull Base. 2009;19:17-25.
https://doi.org/10.1055/s-0028-1103123
70. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, et al. Hereditary phaeochromocytomas and paragangliomas: A study of five susceptibility genes. J Med Genet. 2003;40:e75.
https://doi.org/10.1136/jmg.40.6.e75
71. Asari R, Scheuba C, Kaczirek K, Niederle B. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg. 2006;141:1199-205.
https://doi.org/10.1001/archsurg.141.12.1199
72. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110-6.
https://doi.org/10.1210/jc.2004-1398
https://doi.org/10.1007/s12022-006-0004-2
2. Kantorovich V, Pacak K. Pheochromocytoma and paraganglioma. Prog Brain Res. 2010;182:343-73.
https://doi.org/10.1016/S0079-6123(10)82015-1
3. Glenn F, Gray GF. Functional tumors of the organ of Zuckerkandl. Ann Surg. 1976;183:578-86.
https://doi.org/10.1097/00000658-197605000-00015
4. Roman S. Pheochromocytoma and functional paraganglioma. Curr Opin Oncol. 2004;16:8-12.
https://doi.org/10.1097/00001622-200401000-00003
5. Subramanian A, Maker VK. Organs of Zuckerkandl: Their surgical significance and a review of a century of literature. Am J Surg. 2006;192:224-34.
https://doi.org/10.1016/j.amjsurg.2006.02.018
6. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827-36.
https://doi.org/10.1210/jc.2005-1862
7. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Pheochromocytoma: An update on genetics and management. Endocr Relat Cancer. 2007;14:935-56.
https://doi.org/10.1677/ERC-07-0142
8. Tischler AS, Kimura N, McNicol AM. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann N Y Acad Sci. 2006;1073:557-70.
https://doi.org/10.1196/annals.1353.059
9. McNichol AM. Differential diagnosis of pheochromocytomas and paragangliomas. Endocr Pathol. 2001;12:407-15.
https://doi.org/10.1385/EP:12:4:407
10. McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma. Histopathology. 2010 Aug 16. [Epub ahead of print].
https://doi.org/10.1111/j.1365-2559.2010.03613.x
11. Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med. 2008;132:1272-84.
12. Álvarez TR, Álvarez T, Portela O, Olvera BC, Burgos ZA. Feocromocitoma. Presentación de un caso y revisión de la lite- ratura. Rev Mex Cir Endoscop. 2007;8:148-56.
13. Álvarez R. Feocromocitoma. Presentación de un caso y revisión de la literatura. Asociación Mexicana de Cirugía Endoscópica, AC. 2007;8:148-56.
14. Arroyo-MartínezL,Álvarez-PertuzH,Acuña-CalvoJ,Montoya- Calles J. Paraganglioma funcional extra-adrenal. Acta Méd Costarric. 2006;48:39-42.
15. Hayes WS, Davidson AJ, Grimley PM, Hartman DS. Extraadrenal retroperitoneal paraganglioma: Clinical, pathologic, and CT findings. AJR Am J Roentgenol. 1990;155:1247-50.
https://doi.org/10.2214/ajr.155.6.2173385
16.Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665-75.
https://doi.org/10.1016/S0140-6736(05)67139-5
17. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, et al. Pheochromocytoma: Current approaches and future directions. Oncologist. 2008;13:779-93.
https://doi.org/10.1634/theoncologist.2008-0043
18. Liao CH, Chueh SC, Lai MK, Hsiao PJ, Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab. 2006;91:3080-3.
https://doi.org/10.1210/jc.2005-2420
19. Portela-Gomes GM, Stridsberg M, Grimelius L, Falkmer UG, Falkmer S. Expression of chromogranins A, B, and C secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies. APMIS. 2004;112:663-73.
https://doi.org/10.1111/j.1600-0463.2004.t01-1-apm1121005.x
20. Elder EE, Xu D, Hoog A, Enberg U, Hou M, Pisa P, et al. KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol. 2003;16:246-55.
https://doi.org/10.1097/01.MP.0000056982.07160.E3
21. Sotolongo Y, Vigoa L, Pérez J. Feocromocitoma y anestesia: revisión del tema a propósito de un caso. Rev Cubana Cir [online]. 2002;414). Disponible en http://bvs.sld.cu/revistas/cir/ vol41_4_02/cir11402.htm
22.Mittendorf EA, Evans DB, Lee JE, Perrier ND. Pheochromocytoma: Advances in genetics, diagnosis, localization, and treatment. Hematol Oncol Clin North Am. 2007;21:509-25.
https://doi.org/10.1016/j.hoc.2007.04.012
23. Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am. 2007;21:409-32.
https://doi.org/10.1016/j.hoc.2007.04.006
24. Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G, et al. Laparoscopic surgery for pheochromocytoma: Adrenalectomy, partial resection, excision of paragangliomas. J Urol. 1998;160:330-4.
https://doi.org/10.1016/S0022-5347(01)62886-6
25. Cascon A, Pita G, Burnichon N, Landa I, López-Jiménez E, Montero-Conde C, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab. 2009;94:1701-5.
https://doi.org/10.1210/jc.2008-2756
26. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92:779-86.
https://doi.org/10.1210/jc.2006-2315
27. Malone MJ, Libertino JA, Tsapatsaris NP, Woods BO. Preoperative and surgical management of pheochromocytoma. Urol Clin North Am. 1989;16:567-82.
28. Ilias I, Pacak K. A clinical overview of pheochromocytomas/ paragangliomas and carcinoid tumors. Nucl Med Biol. 2008;35(Suppl.1):S27-34.
https://doi.org/10.1016/j.nucmedbio.2008.04.007
29. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diag- nosis and treatment of pheochromocytoma in an academic hos- pital from 1997 to 2007. Am J Med. 2009;122:85-95.
https://doi.org/10.1016/j.amjmed.2008.08.021
30. Brain KL, Kay J, Shine B. Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population. Clin Chem. 2006;52:2060-4.
https://doi.org/10.1373/clinchem.2006.070805
31. Goldstein DS, Eisenhofer G, Flynn JA, Wand G, Pacak K. Diag- nosis and localization of pheochromocytoma. Hypertension. 2004;43:907-10.
https://doi.org/10.1161/01.HYP.0000125014.56023.b8
32. Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: A clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol. 2005;16:23-32.
https://doi.org/10.1385/EP:16:1:023
33. Fernández-Cruz L, Taura P, Saenz A, Benarroch G, Sabater L. Laparoscopic approach to pheochromocytoma: Hemodynamic changes and catecholamine secretion. World J Surg. 1996;20:762-8.
https://doi.org/10.1007/s002689900116
34. Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL. Pheochromocytoma and paraganglioma: Comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology. 1987;165:89-93.
https://doi.org/10.1148/radiology.165.1.3628794
35. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: Current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging. 2008;52:419-29.
36. van der Harst E, de Herder W, Bruining H, Jaap Bonjer H, de Krijger R, Lamberts S. [123I]Metaiodobenzylguanidine and [111In]Octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab. 2001;86:685-93.
https://doi.org/10.1210/jc.86.2.685
37. van Der Horst-Schrivers AN, Jager Ol, Boenzen HM, Schouten JP, Kema IP, Links TP. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas-experience and meta-analysis. Anticancer Research, 2006;26:1599-604.
38. Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg. 2005;241:919-26.
https://doi.org/10.1097/01.sla.0000164175.26785.06
39. Tiyadath BN, Sukumar S, Saheed CS, Hattangadi SB. Laparoscopic adrenalectomy - is it any different in phaeochromocytoma and non-phaeochromocytoma? Asian J Surg. 2007;30:244-9.
https://doi.org/10.1016/S1015-9584(08)60033-0
40. Misra MC, Bhattacharjee HK, Hemal AK, Bansal VK. Laparoscopic management of rare retroperitoneal tumors. Surg Laparosc Endosc Percutan Tech. 2010;20:e117-22.
https://doi.org/10.1097/SLE.0b013e3181df2286
41. Hwang J, Shoaf G, Uchio EM, Watson J, Pacak K, Linehan WM, et al. Laparoscopic management of extra-adrenal pheochromocytoma. J Urol. 2004;171:72-6.
https://doi.org/10.1097/01.ju.0000102081.46348.a4
42. Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg. 2002;26:1005-12.
https://doi.org/10.1007/s00268-002-6632-x
43. Edwin B, Kazaryan AM, Mala T, Pfeffer PF, Tonnessen TI, Fosse E. Laparoscopic and open surgery for pheochromocytoma. BMC Surg. 2001;1:2.
https://doi.org/10.1186/1471-2482-1-2
44. Mellon MJ, Sethi A, Sundaram CP. Laparoscopic adrenalectomy: Surgical techniques. Indian J Urol. 2008;24:583-9.
https://doi.org/10.4103/0970-1591.44277
45. Kazaryan AM, Kuznetsov NS, Shulutko AM, Beltsevich DG, Edwin B. Evaluation of endoscopic and traditional open approaches to pheochromocytoma. Surg Endosc. 2004;18:937-41.
https://doi.org/10.1007/s00464-003-9199-1
46. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, et al. Malignant pheochromocytoma: Current status and initiatives for future progress. Endocr Relat Cancer. 2004;11:423-36.
https://doi.org/10.1677/erc.1.00829
47. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H. Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 2007;92:1217-25.
https://doi.org/10.1210/jc.2006-1544
48. Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol. 2002;13:149-56.
https://doi.org/10.1385/EP:13:2:149
49. Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551-66.
https://doi.org/10.1097/00000478-200205000-00002
50.Bedard E, Bergeron S, Poirier P, Dumesnil JG. Pheochromocytoma associated with apical-sparing left ventricular dysfunction due to acute afterload mismatch: A no- vel clinical entity? Can J Cardiol. 2007;23:1157-8.
https://doi.org/10.1016/S0828-282X(07)70888-7
51. Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Moretti A, et al. Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodelling. Eur J Endocrinol. 2008;159:137-43.
https://doi.org/10.1530/EJE-08-0126
52. Kim HS, Chang WI, Kim YC, Yi SY, Kil JS, Hahn JY, et al. Catecholamine cardiomyopathy associated with paraganglioma rescued by percutaneous cardiopulmonary support: Inverted Takotsubo contractile pattern. Circ J. 2007;71:1993-5.
https://doi.org/10.1253/circj.71.1993
53. López M, Águila P, González E. Anestesia en el feocromocitoma: presentación de un paciente. Revista Cubana de Anestesiología y Reanimación. 2004;2:45-8.
54. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069-79.
https://doi.org/10.1210/jc.2007-1720
55. Sesay M, Tauzin-Fin P, Gosse P, Ballanger P, Maurette P. Real- time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery. Anesth Analg. 2008;106:164-70.
https://doi.org/10.1213/01.ane.0000289531.18937.0a
56. Carvalho MR, Dias T, Rodrigues A, Machado AP, Esteves R, do C, I. Alpha blockade with doxazosin in pheochromocytoma - report of three cases. Rev Port Cardiol. 2010;29:299-308.
57. Chiu AW. Laparoscopic retroperitoneal adrenalectomy: Clinical experience with 120 consecutive cases. Asian J Surg. 2003;26:139-44.
https://doi.org/10.1016/S1015-9584(09)60372-9
58. Rabii R, Salomon L, Saint F, Hoznek A, Cicco A, Chopin D, et al. Treatment of pheochromocytomas with retroperitoneal laparoscopy. Prog Urol. 2001;11:16-20.
59. Humphrey R, Gray D, Pautler S, Davies W. Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: A review of 47 cases. Can J Surg. 2008;51:276-80.
60. Kasahara T, Nishiyama T, Takahashi K. Laparoscopic adrenalectomy for pheochromocytoma: Evaluation of experience and strategy at a single institute. BJU Int. 2009;103:218-22.
https://doi.org/10.1111/j.1464-410X.2008.07894.x
61. Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92:512-7.
https://doi.org/10.1093/bja/aeh083
62. O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg. 1996;20:916-21.
https://doi.org/10.1007/s002689900139
63. Shirkare S, Kuwert T, Weckesser M, Czech N, Langen KJ, Muller-Gartner HW. Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy. J Postgrad Med. 1994;40:85-7.
64. Chen L, Li F, Zhuang H, Jing H, Du Y, Zeng Z. 99mTc-HYNIC- TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma. J Nucl Med. 2009;50:397-400.
https://doi.org/10.2967/jnumed.108.058693
65. Suh IW, Lee CW, Kim YH, Hong MK, Lee JW, Kim JJ, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation ECMO) in pheochromocytoma. J Korean Med Sci. 2008;23:350-4.
https://doi.org/10.3346/jkms.2008.23.2.350
66. Neumann HP, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab. 2009;94:2677-83.
https://doi.org/10.1210/jc.2009-0496
67. Benn DE, Robinson BG. Genetic basis of phaeochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2006;20:435-50.
https://doi.org/10.1016/j.beem.2006.07.005
68. Jimenez C, Cote G, Arnold A, Gagel RF. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab. 2006;91:2851-8.
https://doi.org/10.1210/jc.2005-2178
69. Boedeker CC, Neumann HP, Offergeld C, Maier W, Falcioni M, Berlis A, et al. Clinical features of paraganglioma syndromes. Skull Base. 2009;19:17-25.
https://doi.org/10.1055/s-0028-1103123
70. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, et al. Hereditary phaeochromocytomas and paragangliomas: A study of five susceptibility genes. J Med Genet. 2003;40:e75.
https://doi.org/10.1136/jmg.40.6.e75
71. Asari R, Scheuba C, Kaczirek K, Niederle B. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg. 2006;141:1199-205.
https://doi.org/10.1001/archsurg.141.12.1199
72. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110-6.
https://doi.org/10.1210/jc.2004-1398
Descargas
Publicado
2010-10-01
Cómo citar
(1)
Cadena, M.; Vergara, A.; Olarte, A.; Ospina González, D. Paraganglioma Del órgano De Zuckerkandl. Rev Colomb Cir 2010, 25, 309-322.
Número
Sección
Presentación de Caso
Licencia
Todos los textos incluidos en la Revista Colombiana de Cirugía están protegidos por derechos de autor. Las opiniones expresadas en los artículos firmados son las de los autores y no coinciden necesariamente con las de los directores o los editores de la Revista Colombiana de Cirugía. Las sugerencias diagnósticas o terapéuticas como elección de productos, dosificación y métodos de empleo corresponden a la experiencia y al criterio de los autores.
Métricas
.jpg)
